They further observed that a GLP-1 receptor agonist reduced neutrophilic airway inflammation by deactivating ILC-2, a key mediator in CRSwNP pathophysiology, in obese mice [35,36]. Here, GLP1R is linked to chronic rhinosinusitis with nasal polyps.